We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Joint FDA Advisory Panel Recommends OTC Approval for Barr's Plan B
Joint FDA Advisory Panel Recommends OTC Approval for Barr's Plan B
September 7, 2005
A joint FDA advisory panel voted this week to recommend that Women’s Capital Corp.’s (WCC’s) prescription “morning after” pill be given OTC status, but ordered the company to perform additional long-term safety studies.
